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Abstract
Background: The use of chromatography coupled with mass spectrometry (MS) analysis is a powerful approach to
identify proteins, owing to its capacity to fractionate molecules according to different chemical features. The first
protein expression map of vascular smooth muscle cells (VSMC) was published in 2001 and since then other
papers have been produced. The most detailed two-dimensional polyacrylamide gel electrophoresis (2D-PAGE)
map was presented by Mayr et al who identified 235 proteins, corresponding to the 154 most abundant unique
proteins in mouse aortic VSMC. A chromatographic approach aimed at fractionating the VSMC proteome has never
been used before.
Results: This paper describes a strategy for the study of the VSMC proteome. Our approach was based on pre-
fractionation with ion exchange chromatography coupled with matrix assisted laser desorption-time of flight mass
spectrometry analysis assisted by a liquid chromatography (LC-MALDI-TOF/TOF). Ion exchange chromatography
resulted in a good strategy designed to simplify the complexity of the cellular extract and to identify a large
number of proteins. Selectivity based on the ion-exchange chemical features was adequate if evaluated on the
basis of protein pI. The LC-MALDI approach proved to be highly reproducible and sensitive since we were able to
identify up to 815 proteins with a concentration dynamic range of 7 orders of magnitude.
Conclusions: In our opinion, the large number of identified proteins and the promising quantitative reproducibility
made this approach a powerful method to analyze complex protein mixtures in a high throughput way and to
obtain statistical data for the discovery of key factors involved in VSMC activation and to analyze a label-free
differential protein expression.
Background
The use of chromatography coupled with MS analysis is
a powerful approach for the identification of proteins,
owing to its capacity to fractionate molecules with dif-
ferent chemical features [1-4]. Furthermore, LC-
MALDI-TOF/TOF analysis combined with preliminary
fractionation of a total protein extract is a potential tool
for biomarker discovery because of its high sensitivity
and high throughput capacity [5].
However, the use of LC-MALDI analysis still needs to
be optimized and evaluated [6,7]. To obtain useful
information for comparative analysis of samples and dif-
ferential protein expression using a label-free approach
in LC-MALDI techniques, the reproducibility in measur-
ing m/z abundances (peak intensity) and a linear rela-
tion between intensity and marker concentration are
essential [8-10]. Moreover, although LC-MALDI MS/
MS analysis is a high mass precision technique, it is
time consuming, especially if applied to a large number
of samples. For this reason a good compromise between
sample pre-processing and high performance liquid
chromatography (HPLC) separation would be necessary
to avoid the masking effect of high abundant proteins
and to evidence hypothetical biomarkers.
We set up and assessed a strategy for rapid data col-
lection coupled with good reproducibility and precision.
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system represented by vascular smooth muscle cells
(VSMC). The cells are characterized by the capability of
switching from a contractile and completely differen-
tiated to a proliferating, migratory phenotype. This
change is mainly due to the stimulation from growth
factors and cytokines that are responsible for cell activa-
tion. Activated VSMCs play a pivotal role in the onset
and progression of cardiovascular diseases, causing the
development of atheromatous plaque and restenotic
lesions [11]. Therefore, great attention has been
focussed on the study of these cells, in order to find the
factors involved in the activation process and/or the bio-
markers of the activated, pathological phenotype, since
these factors could be the putative targets of specific,
innovative therapeutic strategies. In this respect, a pro-
teomic approach is necessary but, up until now, only a
few works have been realized and the great majority car-
ried out with the use of 2D-PAGE. The first map of
VSMC protein expression was published in 2001 [12]
and since then other papers have been produced
[13-17]. The most detailed 2D-PAGE map was pre-
sented by Mayr et al [18] who identified 235 proteins,
corresponding to the 154 most abundant unique pro-
teins, in mouse aortic VSMC. However, this technique
is slow, hindered by the limited dynamic range and not
sufficiently sensitive, especially for the study of hypothe-
tical biomarkers, which are likely to be expressed in
very low concentrations.
For all these reasons, we streamlined a non-conven-
tional, sensitive and reproducible proteomic strategy
that allowed us to identify 815 non-redundant VSMC
proteins. This approach can be easily adapted for more
detailed research and exploited for future analyses in
biomarker discovery.
Results and Discussion
VSMCs cultured under standard conditions with 10%
FBS display a characteristic synthetic, activated pheno-
type (ON-VSMC) endowed with the ability of migrating
and proliferating. Otherwis e ,w h e nl e f ti ns e r u m - f r e e
medium for three days or more, they assume a differen-
tiated quiescent phenotype (OFF-VSMC) able to con-
tract [19]. Serum growth factors and cytokines are
known to be in charge of this phenotypic switch; more-
over, this process is responsible for the onset and pro-
gression of the principal cardiovascular diseases. In
order to optimize methods for the analysis of the activa-
tion mechanism which can eventually be exploited for
biomarker discovery, we analyzed ON- and OFF-VSMC
and also cells maintained for three days in absence of
serum and then activated for 10 minutes with fetal
bovine serum (FBS) (10’-VSMC). The effective change
in cellular phenotype was checked as reported in the
literature [20]. For all three protein extracts the work-
flow we adopted to analyze the VSMC proteome is
reported in figure 1.
Aim of ion-exchange chromatography is to simplify
the total proteome of the cell extract and to avoid the
masking effect due to the excessive complexity and pre-
sence of highly abundant proteins [21].
After sample pre-processing (anion- and cation-
exchange resins), a relatively short HPLC run of a 30
min gradient was chosen in order to obtain a suitable
separation of the peptides and to avoid peptide redun-
dancy in contiguous spots due to an inefficient gradient
rate. The fractions between 10 and 50 minutes were
spotted resulting in approximately 200 spots per sample,
but a preliminary analysis evidenced that only the first
150 fractions were informative. This approach allowed
the spotting of up to 6 samples (all samples of ON,
OFF, 10’ for anion- and cation-exchange chromatogra-
phy) on a single MALDI plate minimizing plate to plate
signal variability, cost and time. The spots were analyzed
using a 4800 MALDI-TOF/TOF mass spectrometer and
the MS/MS data were pre-processed by the manufac-
turer computer program GPS Explorer and identified
using the MASCOT search engine. To evaluate the pos-
sibility of comparing “control” and “activated” samples
through the peptide area and to estimate the “quantita-
tive” reproducibility of the MALDI signal intensity, we
applied four replicated runs and we used an internal
standard of known concentration (ACTH 18-39 frag-
ment) diluted in the matrix (Figure 2). A significant cor-
relation was found between spiked peptide
concentration and intensity in the range of 5 to
20 fmol/μl. The precision of the measure evaluated as
mean CV% between the four replicates was 9.95 ±
1.35%. As a matter of fact, even though MALDI ioniza-
tion is known to yield poor reproducibility of peak
intensity due to the heterogeneous co-crystallization of
the matrix and the peptides [7], a high shot count (we
used 5000 shots/spectra) could lead to greater reprodu-
cibility, as reported in the literature by Hattan et al [9].
To evaluate the efficiency of the ion-exchange resins
we checked pI distribution of the identified proteins.
We divided the identified proteins into three different pI
ranges (3.69-8.99; 9.06-9.99 and 10-12.02) according to
the acidic fraction, while for the cation-exchange the
three pI fractions were 3.76-4.98; 5-5.98 and 6.01-12.02.
Resin performance in terms of selectivity based on ionic
properties proved to be very good, since 80% of the pro-
teins bound to the anionic resin displayed an acid pI
(pI < 8) and 60% of the proteins isolated by the cation-
exchange showed basic pI (pI>6). Furthermore, 73% of
these basic proteins had pI > 8, indicating that this
approach could be used to complement 2D-gel analysis
where high pI proteins are under-represented [22].
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in all technical replicates, has been obtained and the
complete list is reported in “Table-TotalUniqueProteins”
[ s e eA d d i t i o n a lf i l e1 ] .T h es a m p l e s( O N ,O F F ,1 0 ’)i n
which each protein has been identified are specified
together with the chromatographic method (anion-,
cation-exchange). 131 proteins are found only in the
sample ON, 104 in the sample OFF and 133 in the sam-
ple 10’, indicating that every fraction contributes to the
total identified proteins. The number of matched pep-
tides per protein is shown. Single hit proteins resulted
to be 193; corresponding to 24% of the total protein
content.
To estimate the sensitivity of the chromatographic
method coupled to nano-LC-MALDI analysis, we evalu-
ated the number of proteins isolated by both resins
(anion- and cation-exchange). The dynamic range of
concentration covered by this approach was more than
7 orders of magnitude: the most concentrated was actin,
w h i l ew ei d e n t i f i e dt h eh e a ts h o c kp r o t e i nb e t a1 ,al o w
concentrated marker [23]. After protein identification,
we estimated the overlap percentage between anion-
exchange and cation-exchange, which turned out to be
21.8%, suggesting that each resin tends to isolate differ-
ent set of proteins. In particular, in the anion-exchange
we isolated 480 unique proteins, while in the basic frac-
tion we obtained 157 unique proteins. A total of 178
proteins resulted common to the two fractions. The
proteins exclusively identified by the anion-exchanger
represented almost 73% of all proteins, while those
exclusively identified by the cation-exchanger were
almost 47% of the total number of proteins identified.
Even if the two pre-fractionation methods did not work
identically, similar selection efficacies were demon-
strated in the case of SCX and SAX columns for HPLC
applications [24].
The identification of VSMC proteins from their pep-
tide sequences was established with the Swiss-Prot data-
base restricted to mammalian entries and the NCBI
database restricted to Sus scrofa entries. A comparison
was carried out between the two workflows on the basis
of the number of proteins identified by using both
Figure 1 Experimental procedure. It summarizes the experimental procedure we adopted for our study. Proteins from ON- OFF- and 10’-VSMC
were fractionated by ion-exchange chromatography (cation and anion), the ‘specific sample solution’ was tryptic digested and the peptides were
separated by reverse-phase nano-HPLC before MALDI analysis.
Rocchiccioli et al. Proteome Science 2010, 8:15
http://www.proteomesci.com/content/8/1/15
Page 3 of 9databanks. Table 1 evidences the efficiency of MALDI
analysis in mapping the VSMC proteome.
Sensitivity is enhanced with respect to the classical
2D-PAGE without pre-fractionation steps [17] using
pre-treatment with ion-exchange chromatography that
avoids the mask effect due to the complexity of the
whole cell protein extract.
T h em e t r i cf o rt h es u c c e s so ft h i ss t u d yw a st om a x i -
mize sample information concerning identified peptides,
number of proteins and minimum overlap between
cation and anion exchange. The efficiency of the MALDI
analysis strongly influences peptide identification and can
be assessed by MSMS efficiency which compares the
number of MSMS spectra with the number of identified
peptides. We obtained a good performance in both cases
and the comparison of MSMS efficacy in the two data-
banks reflects the strong dependence of sequence identi-
fication on the analysis settings used. While peptides
identified by the SwissProt database all match for anno-
tated protein sequences, peptides recognized by the
NCBI databank only partially match for annotated pro-
teins, more than half being predicted by genome annota-
tions. The number of peptides for each protein
(calculated as an average between the number of peptides
Figure 2 Plot Concentration/Area signal of ACTH standard peptide. It shows the plot of the area/concentration of a standard peptide
(ACTH 18-39 clip, 2465.16 Da) after MALDI-MS analysis by 5000 shots/spot. We performed four replicated runs for each known concentration (5,
10 and 20 fmol/μl) of the standard peptide.
Table 1 Comparison of MALDI efficiency for the workflows with two databanks
workflow MS
Spectra
a)
MSMS
Spectra
b)
Identified
peptides
MSMS
efficiency
(%)
c)
Proteins
d) peptides/
proteins
Proteins by single
peptide
e)
DataBank
f)
1 (Anion) 597 6868 3530 51% 658 5.4 141 SwissProt
(Mammalia)
2 (Cation) 597 6212 2705 43% 335 8.1 139 SwissProt
(Mammalia)
1 (Anion) 597 6868 4232 62% 900
(555Pred)
4.07 53 NCBI
(Sus Scrofa)
2 (Cation) 597 6212 3317 54% 720
(467Pred)
4.07 34 NCBI
(Sus Scrofa)
a) number of total MS spectra/workflow; b) number of total MSMS spectra/workflow; c) efficiency is determined dividing the number of identified peptides per
MSMS spectra; d) number of unique identified proteins. “Pred” is an abbreviation for “Predicted” e) number of proteins identified by a single peptide as reported
by GPS Explorer software; f) database chosen in protein identifications in GPS Explorer software.
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in SwissProt setting, but in NCBI analysis the number of
proteins identified by a single peptide evidences a better
distribution of the peptides within the proteins.
After optimization of pre-fractionation and nano-
LC-MALDI performance, we made a first attempt to
compare the protein contents of activated ON-VSMC
and quiescent OFF-VSMC obtained by anion-exchange.
Significant differences between ON and OFF cells are
made evident by simply comparing their UV profiles
after HPLC separation of the peptide mixtures. Instead,
the 10’-VSMC and OFF-VSMC UV profiles are strictly
superimposed (Figure 3) as we expected, since in the
early phase of activation post-translational modifications
such as phosphorylation generally occur, while a differ-
ential protein expression is untimely [25]. For these rea-
sons, to analyze the differences between activated and
quiescent cells we concentrated our attention on ON
and OFF samples.
The identified proteins in anion-exchange were
grouped in functional classes and the differences
between ON and OFF cells reported in figure 4. As a
preliminary result, we can observe that major variations
are related to cytoskeleton, chaperones, cell cycle, fac-
tors associated with protein synthesis and enzyme
responsible of the energetic metabolism.
It is first interesting to observe how chaperones and
enzymes involved in protein synthesis and energy meta-
bolism are outnumbered in the activated cells. This phe-
notype is in fact characterized by the incentive of
proliferation and migration and also by an impressive
increase in protein synthesis [11,26]. It is encouraging to
observe that proteins related to migration are more
represented in activated cells (4% vs 2%), while the
opposite is true for cytoskeleton elements implied with
contraction (13% vs 24%). Moreover, proteins involved
in the inhibition of cell proliferation or apoptosis are
more numerous in quiescent VSMC, but proteins acti-
vating cell cycle progression are more represented in
activated VSMC (5% vs 1%).
A preliminary comparative investigation was carried
out to analyze the differential peptide and protein
expression in the two different phenotypes. We used the
aligned peak lists obtained by MarkerView [27] and two
technical replicates for every sample (quiescent-OFF and
activated-ON VSMC), with particular attention to some
proteins clearly involved in functions undoubtedly sti-
mulated by the growth factor. Identified peptides corre-
sponding to a given protein were analyzed in order to
follow the general trend. The result was encouraging
since for the majority of the factors related to cytoskele-
ton remodelling responsible for cell motility an over-
expression in activated VSMC was evidenced. We report
the results obtained for two proteins, as examples
(Figure 5).
VSMCs grown with 10% FBS for up to three days
(ON) display completely different features and functions
compared to the contractile-quiescent cells cultured in
absence of serum (OFF); as a matter of fact, the exis-
tence of two distinctive phenotypes, one contractile and
healthy, the other activated and pathological, has long
been recognized.
Conclusions
Ion-exchange chromatography is a suitable strategy
aimed at simplifying the complexity of the cellular
extract and at identifying a large number of proteins.
The efficiency based on the ion-exchange chemical
Figure 3 HPLC UV Profile Overlap. It shows the overlap of the UV profiles, measured by nano-HPLC at 214 nm wavelength of anion-exchange
LC-runs in ON, OFF and 10 min “specific sample solutions”
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tein pI. The LC-MALDI approach was reproducible and
sensitive since we were able to identify up to 815 pro-
teins with a dynamic range of 7 orders of magnitude.
Moreover, this approach could be easily integrated with
other chromatographic media, more useful and selective
for post-translational modifications and phospho-specific
chromatographic methods such as IMAC, SIMAC or
TiO2 useful to analyze the early events of VSMC activa-
tion. In our opinion, the large number of identified pro-
teins and the promising quantitative reproducibility have
made this approach a powerful method to analyze com-
plex protein mixtures in a high throughput way and to
obtain statistical data for the discovery of key factors
involved in VSMC activation and to analyze a label-free
differential protein expression.
Methods
Chemicals, standards and consumables
ACN and TFA used for LC-MS analysis or sample pre-
paration were of HPLC quality (Sigma Aldrich, St Louis,
USA); HPLC-grade water was prepared by a Milli-Q
purification system (Millipore, Billerica, MA, USA);
sequencing-grade trypsin for protein digestion was from
Roche (Mannheim, Germany). BCA-Protein Assay for
the determination of protein concentration was from
Pierce (Rockford, IL, USA). All other chemicals used for
sample preparation were reagent-grade from Sigma (St
Louis, MO, USA).
Isolation of VSMC and culture conditions
Coronaries were dissected from the myocardium of
8-month-old domestic crossbred pigs (Sus scrofa
Figure 4 Classification of identified proteins. It shows identified protein distribution by selected functions respectively for ON and OFF cells.
Figure 5 Plot response/peptide m/z for two identified proteins in OFF and ON cells. It shows the response of selected peptides (in terms
of peptide area) in mass spectrometry recovered in OFF-VSMC (two technical replicates) and ON-VSMC (two technical replicates). The medium
value of the response for every peptide and the error bars are reported. a) The selected peptides for Radixin are m/z 1) 987.5, .2)1104.5, 3)
1231.5, 4)1248.6, 5)2080.0 b) The selected peptides for PDI-A3 are m/z 1) 1172.5, 2)1191.6, 3)1359.6, 4)1664.7. Two interesting proteins are chosen
and identified peptides are selected to analyze their general trend during the activation.
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digestion and cultured according to the method
described by Christen et al [19]. All experiments
reported in this study were performed with VSMC at
the sixth passage and, unless otherwise specified, from
at least three different explants. The investigation was
conformed to the Ministerial Decree to authorize testing
n.06/2009-B of 26/01/2009.
Protein extraction
VSMC pellets from about 10
7 VSMCs were suspended
in 500 μl of ice-cold lysis medium containing 50 mM
Tris-HCl pH 8; 0.5% Triton X-100; 0.25% deoxycholic
acid. Cells were sonicated (SoniPrep 150 MSE) 5 times
(10 seconds sonication and 20 seconds rest in ice) and
centrifuged (Centrifuge Eppendorf 5415R and a stan-
dard rotor F45-24-11, 11 mm diameter) at 10500 × g at
4°C for 30 min, gently vortexed and re-centrifuged for
15 min under the same conditions. The protein concen-
tration was determined by BCA (bi-cinchoninic acid)
and the protein samples were lyophilized.
Protein fractionation
1.2 mg of each protein sample (OFF-quiescent cells,
ON-activated cells, 10’-cells activated for 10 minutes
with FBS) was re-suspended in 100 μl of water and split
in two parts, one for anion-exchange chromatographic
fractionation and the other for cation-exchange.
Cation-exchange chromatographic fractionation
Cation-exchange columns were prepared using Mobicol
column (Mo Bi Tec, Göttingen, Germany) filled with
250 μl of strong cation-exchanger resin (500 μlo fs l u r r y
Unosphere S, Biorad). Each resin was centrifuged to
remove the storage solution. They were washed with
formic acid/NH3 pH 5.7 (binding buffer I) and centri-
fuged at 9300 × g for 30 sec; the wash was repeated
twice. 450 μl of binding buffer I were added to the sam-
ples. The obtained solutions were loaded and fluttered
u p - d o w no nt h ec o l u m nf o r1 5m i na t4 ° C .T h ec o l -
umns were centrifuged at 9300 × g for 30 sec and
washed with 150 μl of binding buffer I. The aspecific
sample was discarded. Columns were washed with 0.5
ml of binding buffer I, vortexed and centrifuged twice at
9300 × g for 30 sec and the operation was repeated with
0.5 ml of water to favour pH change.
Elution of the specific fractions was carried out with
0.5 ml of elution buffer containing 5% NH4OH, 1 M
NaCl, pH 11.8. The columns were fluttered up-down
for 15 min at 4°C, centrifuged at 9300 × g for 30 sec
and washed twice with 150 μl of elution buffer; the
eluted was stored (named “specific” cationic sample
solution). All samples were lyophilized.
Anion-exchange chromatographic fractionation
Anion-exchange columns were prepared using Mobicol
column (Mo Bi Tec, Göttingen, Germany) filled with
250 μl of strong anion-exchanger resin (500 μl of slurry
Unosphere Q, Biorad). Each resin was centrifuged to
remove the storage solution. They were washed with
200 mM Tris/HCl, pH 8.5 (binding buffer II) and centri-
fuged at 9300 × g for 30 sec; the wash was repeated
twice. 450 μl of binding buffer II were added to the
samples. The obtained solutions were loaded and flut-
tered up-down on the column for 15 min at 4°C. The
columns were centrifuged at 9300 × g for 30 sec and
washed with 150 μl of binding buffer II. The aspecific
sample was discarded. Columns were washed with
0.5 ml of binding buffer II, vortexed and centrifuged
t w i c ea t9 3 0 0×gf o r3 0s e ca n dt h eo p e r a t i o nw a s
repeated with 0.5 ml of water to favour pH change.
The columns were fluttered up-down for 15 min at 4°
C, centrifuged at 9300 × g for 30 sec and washed twice
with 150 μl of elution buffer (200 mM formic acid/NH3
pH = 2.5); the eluted was stored and named “specific”
anionic sample solution. All samples were lyophilized.
Reduction, alkylation and digestion
Lyophilized protein mixtures of samples were suspended
in 250 μlo f2 0m Ma m m o n i u mh y d r o g e nc a r b o n a t e
pH 8. Reduction was performed adding 25 μlo f5 0m M
DTT to each sample which was made to react at 80°C for
20 min. Samples were allowed to cool at room tempera-
ture and 12.5 μl 200 mM iodoacetamide were added for
30 min at 37°C. Digestion was performed adding 7.5 μlo f
trypsin solution (solution 0.25 mg/ml) at 37°C overnight.
Peptide separation using Nano-HPLC
Chromatographic separation of peptides was performed
using an Ultimate 3000 nano-HPLC system (LC Packings,
DIONEX, Sunnyvale, USA). 37.5 μl of 0.2% TFA up to 150
μl with water was added to 50 μlo fe a c hs a m p l ea n df i l -
trated with 0.45 μm filter. The loading pump ensured pre-
concentration of the sample in a μ-precolumn cartridge
(PepMap-100 C18 5 μm 100A, 30 μm idx5 mm). Chroma-
tographic separation of peptides was performed using a
C18 PepMap-100 column (15 cm × 75 μm i.d., LC Pack-
ings DIONEX) and using a linear gradient of B, a mixture
of acetonitrile/water (80:20) with 0.05% TFA, in solvent A,
a mixture of water/acetonitrile (98:2) with 0.04% TFA as
follows: from 10% to 45% of B in 30 min, switched to
100% buffer B for 10 min, followed by 20 min re-equilibra-
tion with buffer A at a constant flow rate of 0.3 μl/min.
The column was directly coupled to a UV flow cell detec-
tor (214 nm-Ultimate DIONEX) at the exit of which the
effluent was coaxially mixed with a solution of 2 mg/ml a-
cyano-4-hydroxycinnamic acid MALDI matrix (a-CHCA)
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delivered at a flow rate of 1.9 μl/min, then directed
towards an on-line Probot (LC Packings DIONEX) plate-
spotting system (MALDI plate containing 1664 total wells-
ABSCIEX). The injection of each sample was replicated
twice. Before and after sample analysis, two blank injec-
tions were performed to minimize carry-over. Each spot
represented a 12-second “fraction” of the reverse phase
gradient. The runs of each sample, each containing 200
spots, were distributed on the same MALDI plate.
MALDI MS data acquisition
Spots representing the different chromatographic frac-
tions were analyzed using a 4800 MALDI-TOF/TOF
mass spectrometer (Applied Biosystems/MDS Sciex,
Toronto, Canada), equipped with a laser emitting at l =
355 nm with a repetition rate of 200 Hz. The mass
spectrometer was controlled by the 4000 Series
Explorer, version 3.5.2 program. For MS analyses, typi-
cally 2000 spectra were acquired for each spot in the
reflector positive mode in the mass range of 650 to
4000 m/z, with 50 ppm mass tolerance (external and
internal calibration). The spots of fractions eluted before
10 min and after 50 min were not analyzed for the sake
of time, as preliminary investigations showed that they
apparently contained very little peptide information.
MS data processing and analysis
Peak lists obtained from Nano-LC-MALDI-TOF chro-
matograms were processed using MarkerView version
1.2 (Applied Biosystems/MDS Sciex, Toronto, Canada).
Alignment was first performed with 2 min retention
time and 0.2 amu mass tolerance for all technical repli-
cates of OFF- and ON-VSMC. These settings were opti-
mized values found to give a maximum number of
common peaks between samples. Then, the data were
scaled in intensity by normalization by total area sum
using MarkerView. After alignment and normalization,
t h ed a t aw e r ef i l t e r e do u tf r o mM A L D Ir e s i d u a la-
CHCA matrix clusters. As most matrix clusters had
masses below 700 m/z, filtration consisted in excluding
all ions with m/z < 700. The aligned peak lists were
used to plot profiles of interest peptides in the activated
vs non-activated samples and to extract preliminary
information on differential peptide/protein expression.
MALDI MSMS data acquisition and protein identification
MS/MS data acquisition was performed on all runs in
the MALDI for the best 15 precursor ions. MS/MS
acquisitions were then carried out using air as collision
gas at a pressure of ~3.0 × 10
6 torr and collision energy
of 1 kV. Approximately 2000 spectra were added up for
each spot. The peaks were de-isotoped and only those
with s/n >5 were retained for interpretation.
MSMS data were pre-processed by the manufacturer
computer program GPS Explorer version 3.6 (Applied
Biosystems). Identification of pig proteins from their
peptide sequences was established using MASCOT
search engine version 2.1 (Matrix Science, Boston, MA)
with the last updated version of Swiss-Prot protein data-
base for Mammalia and UniGene database (NCBI) for
Sus Scrofa (UniGene Built #37 Entries: 51,692). Methio-
nine oxidation, Asn and Gln deamidation, Thr, Ser and
Tyr phosphorylation and acetylation were selected as
variable modifications. The tolerance for precursor ion
and MS/MS fragment mass values was set at 50 ppm
and 0.3 Da, respectively. Trypsin digestion and two pos-
sible missed cleavages were used. Only the 2 top-ranked
peptide matches were taken into consideration for pro-
tein identification. Proteins with total ion score CI %>
97 (this parameter combines p-value for MSMS identifi-
cation with MASCOT score) were accepted.
Quantitative response and performance of MALDI-TOF/
TOF analysis
Quantitative accuracy and reproducibility of MALDI-
TOF/TOF were evaluated using an internal standard
(ACTH 18-39 fragment, m/z 2465.16) added to the
MALDI matrix and spotted along all the LC profile in
known amount and in the same concentration in every
spot. Three different concentrations (5-20 fmol/μl) were
used to evaluate the linear increase of intensity with
peptide concentration increase. Four replicates of each
concentration were used to evaluate reproducibility.
Additional file 1: Table-TotalUniqueProteins. In the table total unique
proteins are reported. The samples (ON, OFF, 10’) in which each protein
has been identified are specified, together with the chromatographic
method (anion-, cation-exchange).
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